These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31602785)

  • 1. The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome.
    O'Brien R; O'Malley D
    Neurogastroenterol Motil; 2020 Feb; 32(2):e13738. PubMed ID: 31602785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
    Buckley MM; O'Brien R; Buckley JM; O'Malley D
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13684. PubMed ID: 31311066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
    J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI 3-kinase- and ERK-MAPK-dependent mechanisms underlie Glucagon-Like Peptide-1-mediated activation of Sprague Dawley colonic myenteric neurons.
    O'Brien R; Buckley MM; Kelliher A; O'Malley D
    Neurogastroenterol Motil; 2019 Aug; 31(8):e13631. PubMed ID: 31121089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models.
    Chen Y; Li Z; Yang Y; Lin L; Zhang H
    Int J Mol Med; 2013 Mar; 31(3):607-13. PubMed ID: 23338623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome.
    O'Malley D
    Exp Physiol; 2019 Jan; 104(1):3-10. PubMed ID: 30444291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction.
    O'Mahony SM; Bulmer DC; Coelho AM; Fitzgerald P; Bongiovanni C; Lee K; Winchester W; Dinan TG; Cryan JF
    Neurogastroenterol Motil; 2010 May; 22(5):573-8, e124. PubMed ID: 20003079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
    Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
    World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effects of exendin-4 and interleukin-6 on rat colonic secretory and contractile activity are associated with changes in regional vagal afferent signaling.
    O'Brien R; Buckley MM; O'Malley D
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14160. PubMed ID: 33945195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the prokinetic effects of endogenous glucagon-like peptide-1 in the rat proximal colon.
    Nakamori H; Iida K; Hashitani H
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G617-G627. PubMed ID: 34643099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin modifies the prosecretory and prokinetic effects of the inflammatory cytokine interleukin-6 on colonic function in Sprague-Dawley rats.
    Buckley MM; O'Brien R; Devlin M; Creed AA; Rae MG; Hyland NP; Quigley EM; McKernan DP; O'Malley D
    Exp Physiol; 2016 Dec; 101(12):1477-1491. PubMed ID: 27676233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors.
    Amato A; Cinci L; Rotondo A; Serio R; Faussone-Pellegrini MS; Vannucchi MG; Mulè F
    Neurogastroenterol Motil; 2010 Jun; 22(6):664-e203. PubMed ID: 20158614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR; Luo JY; Shang L; Kong WM
    Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
    Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
    Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats.
    Zhang J; Yi T; Cheng S; Zhang S
    Int Immunopharmacol; 2020 Sep; 86():106715. PubMed ID: 32570036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated inhibition of small bowel migrating complex by GLP-1 analog ROSE-010 delivered via pulmonary and systemic routes in the conscious rat.
    Hellström PM; Smithson A; Stowell G; Greene S; Kenny E; Damico C; Leone-Bay A; Baughman R; Grant M; Richardson P
    Regul Pept; 2012 Nov; 179(1-3):71-6. PubMed ID: 22960405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression and secretion of colonic interleukin-6 in a stress-sensitive animal model of brain-gut axis dysfunction.
    O'Malley D; Dinan TG; Cryan JF
    J Neuroimmunol; 2011 Jun; 235(1-2):48-55. PubMed ID: 21565410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome.
    Gibney SM; Gosselin RD; Dinan TG; Cryan JF
    Neuroscience; 2010 Feb; 165(3):675-83. PubMed ID: 19765638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion.
    O'Malley D; Cryan JF; Dinan TG
    Brain Behav Immun; 2013 May; 30():115-24. PubMed ID: 23369733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.